Sandrine Buisson

533 total citations
8 papers, 423 citations indexed

About

Sandrine Buisson is a scholar working on Immunology, Virology and Oncology. According to data from OpenAlex, Sandrine Buisson has authored 8 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 2 papers in Virology and 2 papers in Oncology. Recurrent topics in Sandrine Buisson's work include Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). Sandrine Buisson is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). Sandrine Buisson collaborates with scholars based in France, United Kingdom and United States. Sandrine Buisson's co-authors include Frédéric Triebel, Susanne Andreae, Bent K. Jakobsen, Giovanna Bossi, Namir J. Hassan, Frances Gotch, Steven Patterson, Adel Benlahrech, Peter Kelleher and Brian Gazzard and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Infectious Diseases.

In The Last Decade

Sandrine Buisson

8 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandrine Buisson France 8 287 181 53 52 40 8 423
Fabio Jimenez United States 9 232 0.8× 102 0.6× 124 2.3× 71 1.4× 23 0.6× 11 456
Sarah Alter United States 11 660 2.3× 435 2.4× 83 1.6× 51 1.0× 64 1.6× 19 839
Kunihiko Tamaki Japan 10 202 0.7× 58 0.3× 87 1.6× 30 0.6× 26 0.7× 12 416
Laura Salogni Italy 7 226 0.8× 147 0.8× 152 2.9× 32 0.6× 12 0.3× 8 439
Ryan J. Martinez United States 14 597 2.1× 151 0.8× 143 2.7× 15 0.3× 58 1.4× 27 780
Martine Reijm Netherlands 6 344 1.2× 107 0.6× 24 0.5× 31 0.6× 31 0.8× 10 451
Tahsin N. Khan United States 10 494 1.7× 66 0.4× 66 1.2× 10 0.2× 25 0.6× 10 572
Takehito Imado Japan 8 206 0.7× 28 0.2× 87 1.6× 81 1.6× 26 0.7× 10 341
Hernan Martinez United States 9 160 0.6× 88 0.5× 88 1.7× 14 0.3× 50 1.3× 15 355
Devangi Mehta United States 8 461 1.6× 130 0.7× 65 1.2× 11 0.2× 27 0.7× 16 637

Countries citing papers authored by Sandrine Buisson

Since Specialization
Citations

This map shows the geographic impact of Sandrine Buisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Buisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Buisson more than expected).

Fields of papers citing papers by Sandrine Buisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Buisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Buisson. The network helps show where Sandrine Buisson may publish in the future.

Co-authorship network of co-authors of Sandrine Buisson

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Buisson. A scholar is included among the top collaborators of Sandrine Buisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Buisson. Sandrine Buisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Yang, Hongbing, Sandrine Buisson, Giovanna Bossi, et al.. (2016). Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors. Molecular Therapy. 24(11). 1913–1925. 31 indexed citations
2.
Bossi, Giovanna, et al.. (2014). ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells. Cancer Immunology Immunotherapy. 63(5). 437–448. 56 indexed citations
3.
Edmonds, E.V.J., Geraint Barton, Sandrine Buisson, et al.. (2011). Gene expression profiling in male genital lichen sclerosus. International Journal of Experimental Pathology. 92(5). 320–325. 34 indexed citations
4.
Buisson, Sandrine, Adel Benlahrech, Brian Gazzard, et al.. (2009). Monocyte‐Derived Dendritic Cells from HIV Type 1–Infected Individuals Show Reduced Ability to Stimulate T Cells and Have Altered Production of Interleukin (IL)–12 and IL‐10. The Journal of Infectious Diseases. 199(12). 1862–1871. 41 indexed citations
5.
Buisson, Sandrine & Frédéric Triebel. (2005). LAG‐3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors. Immunology. 114(3). 369–374. 56 indexed citations
6.
Morand, Stanislas, Marie‐Sophie Noël‐Hudson, Valérie Nicolas, et al.. (2004). Targeting of the Dual Oxidase 2 N-terminal Region to the Plasma Membrane. Journal of Biological Chemistry. 279(29). 30244–30251. 34 indexed citations
7.
Buisson, Sandrine & Frédéric Triebel. (2003). MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells. Vaccine. 21(9-10). 862–868. 41 indexed citations
8.
Andreae, Susanne, Sandrine Buisson, & Frédéric Triebel. (2003). MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood. 102(6). 2130–2137. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026